Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Metabolomic Understanding of variable risk factors for kidney cancer: a two-sample Mendelian randomization study

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:37
  • Read more about Metabolomic Understanding of variable risk factors for kidney cancer: a two-sample Mendelian randomization study

The causal effect of gut microbiome on pulmonary artery hypertension based on a two-sample Mendelian randomization study

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:35
  • Read more about The causal effect of gut microbiome on pulmonary artery hypertension based on a two-sample Mendelian randomization study

Causal association between non-steroidal anti-inflammatory drugs use and the risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:33
  • Read more about Causal association between non-steroidal anti-inflammatory drugs use and the risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study

Identification of hub gene associated with colorectal cancer: Integrating Mendelian randomization, transcriptome analysis and experimental verification

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:32
  • Read more about Identification of hub gene associated with colorectal cancer: Integrating Mendelian randomization, transcriptome analysis and experimental verification

Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:27
  • Read more about Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications

Causal relationships between gut microbiota and urothelial carcinoma mediated by inflammatory cytokines and blood cell traits identified through Mendelian randomization analysis.

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:25
  • Read more about Causal relationships between gut microbiota and urothelial carcinoma mediated by inflammatory cytokines and blood cell traits identified through Mendelian randomization analysis.

Multi-omics analysis unveiled fibroblast-mediated pathogenesis in male genital lichen sclerosus

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:22
  • Read more about Multi-omics analysis unveiled fibroblast-mediated pathogenesis in male genital lichen sclerosus

Multi-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas

Submitted by Anna Hakala on Thu, 10/30/2025 - 12:18
  • Read more about Multi-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas

Exploring causal relationships between brain imaging-derived phenotypes and ovarian cancer risk: a bidirectional Mendelian randomization

Submitted by Anna Hakala on Wed, 10/29/2025 - 13:44
  • Read more about Exploring causal relationships between brain imaging-derived phenotypes and ovarian cancer risk: a bidirectional Mendelian randomization

No evidence of a causal relationship between negative emotions and glaucoma: evidence triangulation from genetic correlation, Mendelian randomisation and colocalisation

Submitted by Anna Hakala on Wed, 10/29/2025 - 12:41
  • Read more about No evidence of a causal relationship between negative emotions and glaucoma: evidence triangulation from genetic correlation, Mendelian randomisation and colocalisation

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Current page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement